$UROV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Urovant Sciences Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Urovant Sciences Ltd.. Get notifications about new insider transactions in Urovant Sciences Ltd. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 12 2021 | UROV | Urovant Sciences L ... | Robinson James A. Jr. | PEO; CEO/Urovant Sc ... | Payment of Exercise | F | 16.11 | 4,095 | 65,970 | 8,385 | 12.5 K to 8.4 K (-32.81 %) |
Jan 08 2021 | UROV | Urovant Sciences L ... | Haag-Molkenteller Cornelia | CMO/Urovant Science ... | Payment of Exercise | F | 16.09 | 5,810 | 93,483 | 141,348 | 147.2 K to 141.3 K (-3.95 %) |
Jan 08 2021 | UROV | Urovant Sciences L ... | Smith Bryan E. | GC/Urovant Sciences ... | Payment of Exercise | F | 16.09 | 4,761 | 76,604 | 124,447 | 129.2 K to 124.4 K (-3.68 %) |
Jul 23 2020 | UROV | Urovant Sciences L ... | Hindman James M. | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
Jul 23 2020 | UROV | Urovant Sciences L ... | Hindman James M. | Director | Grant | A | 0.00 | 9,000 | 0 | 9,000 | 0 to 9 K |
Jul 23 2020 | UROV | Urovant Sciences L ... | Legault Pierre | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
Jul 23 2020 | UROV | Urovant Sciences L ... | Legault Pierre | Director | Grant | A | 0.00 | 9,000 | 0 | 21,480 | 12.5 K to 21.5 K (+72.12 %) |
Jul 23 2020 | UROV | Urovant Sciences L ... | POTTER MYRTLE S | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
Jul 23 2020 | UROV | Urovant Sciences L ... | POTTER MYRTLE S | Director | Grant | A | 0.00 | 9,000 | 0 | 21,480 | 12.5 K to 21.5 K (+72.12 %) |
Jul 23 2020 | UROV | Urovant Sciences L ... | Kurstjens Sef | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
Jul 23 2020 | UROV | Urovant Sciences L ... | Kurstjens Sef | Director | Grant | A | 0.00 | 9,000 | 0 | 21,480 | 12.5 K to 21.5 K (+72.12 %) |
Jun 03 2020 | UROV | Urovant Sciences L ... | Johnston Walt | SVP, Commercial, US ... | Option Exercise | A | 10.64 | 69,197 | 736,256 | 69,197 | |
Jun 03 2020 | UROV | Urovant Sciences L ... | Johnston Walt | SVP, Commercial, US ... | Grant | A | 0.00 | 108,647 | 0 | 108,647 | 0 to 108.6 K |
Jun 01 2020 | UROV | Urovant Sciences L ... | Hindman James M. | Director | Option Exercise | A | 10.53 | 61,000 | 642,330 | 61,000 | |
May 04 2020 | UROV | Urovant Sciences L ... | Haag-Molkenteller Cornelia | CMO/Urovant Science ... | Grant | A | 0.00 | 83,149 | 0 | 145,277 | 62.1 K to 145.3 K (+133.83 %) |
May 04 2020 | UROV | Urovant Sciences L ... | Smith Bryan E. | GC/Urovant Sciences ... | Grant | A | 0.00 | 77,606 | 0 | 127,606 | 50 K to 127.6 K (+155.21 %) |
May 04 2020 | UROV | Urovant Sciences L ... | OCAMPO CHRISTINE | PAO;CAO/Urovant Sci ... | Grant | A | 0.00 | 44,346 | 0 | 77,179 | 32.8 K to 77.2 K (+135.07 %) |
May 04 2020 | UROV | Urovant Sciences L ... | BANSAL AJAY | PFO;CFO/Urovant Sci ... | Grant | A | 0.00 | 63,659 | 0 | 138,659 | 75 K to 138.7 K (+84.88 %) |
Mar 25 2020 | UROV | Urovant Sciences L ... | Robinson James A. Jr. | PEO;CEO/Urovant Sci ... | Option Exercise | A | 9.16 | 845,732 | 7,746,905 | 845,732 | |
Feb 21 2020 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Option Exercise | M | 3.86 | 180,000 | 694,800 | 701,254 | |
Feb 21 2020 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Sell | J | 13.08 | 75,212 | 983,773 | 199,680 | 274.9 K to 199.7 K (-27.36 %) |
Feb 21 2020 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Payment of Exercise | F | 13.08 | 104,788 | 1,370,627 | 274,892 | 379.7 K to 274.9 K (-27.60 %) |
Feb 21 2020 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Buy | M | 3.86 | 180,000 | 694,800 | 379,680 | 199.7 K to 379.7 K (+90.14 %) |
Feb 21 2020 | UROV | Urovant Sciences L ... | Smith Bryan E. | GC/Urovant Sciences ... | Option Exercise | M | 6.88 | 50,000 | 344,000 | 20,000 | |
Feb 21 2020 | UROV | Urovant Sciences L ... | Smith Bryan E. | GC/Urovant Sciences ... | Sell | J | 13.08 | 15,165 | 198,358 | 50,000 | 65.2 K to 50 K (-23.27 %) |
Feb 21 2020 | UROV | Urovant Sciences L ... | Smith Bryan E. | GC/Urovant Sciences ... | Payment of Exercise | F | 13.08 | 34,835 | 455,642 | 65,165 | 100 K to 65.2 K (-34.83 %) |
Feb 21 2020 | UROV | Urovant Sciences L ... | Smith Bryan E. | GC/Urovant Sciences ... | Buy | M | 6.88 | 50,000 | 344,000 | 100,000 | 50 K to 100 K (+100.00 %) |
Feb 21 2020 | UROV | Urovant Sciences L ... | Sumitomo Chemical Co., Ltd. | Buy | P | 13.08 | 75,212 | 983,773 | 22,963,263 | 22.9 M to 23 M (+0.33 %) | |
Feb 21 2020 | UROV | Urovant Sciences L ... | Sumitomo Chemical Co., Ltd. | Buy | P | 13.08 | 15,165 | 198,358 | 22,888,051 | 22.9 M to 22.9 M (+0.07 %) | |
Feb 21 2020 | UROV | Urovant Sciences L ... | Sumitomo Chemical Co., Ltd. | Buy | P | 13.08 | 12,873 | 168,379 | 22,872,886 | 22.9 M to 22.9 M (+0.06 %) | |
Jan 14 2020 | UROV | Urovant Sciences L ... | Robinson James A. Jr. | Director | Grant | A | 0.00 | 12,480 | 0 | 12,480 | 0 to 12.5 K |
Jan 14 2020 | UROV | Urovant Sciences L ... | POTTER MYRTLE S | Director | Grant | A | 0.00 | 12,480 | 0 | 12,480 | 0 to 12.5 K |
Jan 14 2020 | UROV | Urovant Sciences L ... | Legault Pierre | Director | Grant | A | 0.00 | 12,480 | 0 | 12,480 | 0 to 12.5 K |
Jan 14 2020 | UROV | Urovant Sciences L ... | Kurstjens Sef | Director | Grant | A | 0.00 | 12,480 | 0 | 12,480 | 0 to 12.5 K |
Jan 09 2020 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Grant | A | 0.00 | 199,680 | 0 | 199,680 | 0 to 199.7 K |
Jan 09 2020 | UROV | Urovant Sciences L ... | Haag-Molkenteller Cornelia | CMO/Urovant Science ... | Grant | A | 0.00 | 62,128 | 0 | 62,128 | 0 to 62.1 K |
Jan 09 2020 | UROV | Urovant Sciences L ... | OCAMPO CHRISTINE | PAO;CAO/Urovant Sci ... | Grant | A | 0.00 | 32,833 | 0 | 32,833 | 0 to 32.8 K |
Jan 09 2020 | UROV | Urovant Sciences L ... | Smith Bryan E. | GC/Urovant Sciences ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Dec 31 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Sell | S | 0.00 | 22,860,013 | 0 | 0 | 22.9 M to 0 (-100.00 %) |
Dec 31 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Sell | S | 0.00 | 22,860,013 | 0 | 0 | 22.9 M to 0 (-100.00 %) |
Dec 11 2019 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Option Exercise | M | 3.86 | 120,000 | 463,200 | 881,254 | |
Dec 11 2019 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Sell | S | 12.78 | 120,000 | 1,533,600 | 0 | 120 K to 0 (-100.00 %) |
Dec 11 2019 | UROV | Urovant Sciences L ... | Katkin Keith | PEO;CEO/Urovant Sci ... | Buy | M | 3.86 | 120,000 | 463,200 | 120,000 | 0 to 120 K |
Nov 05 2019 | UROV | Urovant Sciences L ... | BANSAL AJAY | PFO;CFO/Urovant Sci ... | Option Exercise | A | 9.66 | 140,000 | 1,352,400 | 140,000 | |
Nov 05 2019 | UROV | Urovant Sciences L ... | BANSAL AJAY | PFO;CFO/Urovant Sci ... | Grant | A | 0.00 | 75,000 | 0 | 75,000 | 0 to 75 K |
Jul 11 2019 | UROV | Urovant Sciences L ... | Torti Frank | Director | Option Exercise | A | 8.78 | 25,000 | 219,500 | 25,000 | |
Jul 11 2019 | UROV | Urovant Sciences L ... | Robinson James A. Jr. | Director | Option Exercise | A | 8.78 | 25,000 | 219,500 | 25,000 | |
Jul 11 2019 | UROV | Urovant Sciences L ... | POTTER MYRTLE S | Director | Option Exercise | A | 8.78 | 25,000 | 219,500 | 25,000 | |
Jul 11 2019 | UROV | Urovant Sciences L ... | Legault Pierre | Director | Option Exercise | A | 8.78 | 25,000 | 219,500 | 25,000 | |
Jul 11 2019 | UROV | Urovant Sciences L ... | Kurstjens Sef | Director | Option Exercise | A | 8.78 | 25,000 | 219,500 | 25,000 | |
Jun 19 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.17 | 4,957 | 40,495 | 22,860,013 | 22.9 M to 22.9 M (+0.02 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.21 | 6,706 | 55,061 | 22,855,056 | 22.8 M to 22.9 M (+0.03 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.53 | 6,541 | 55,825 | 22,848,350 | 22.8 M to 22.8 M (+0.03 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.17 | 4,957 | 40,495 | 22,860,013 | 22.9 M to 22.9 M (+0.02 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.21 | 6,706 | 55,061 | 22,855,056 | 22.8 M to 22.9 M (+0.03 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.53 | 6,541 | 55,825 | 22,848,350 | 22.8 M to 22.8 M (+0.03 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 8.17 | 4,957 | 40,495 | 22,860,013 | 22.9 M to 22.9 M (+0.02 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 8.21 | 6,706 | 55,061 | 22,855,056 | 22.8 M to 22.9 M (+0.03 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 8.53 | 6,541 | 55,825 | 22,848,350 | 22.8 M to 22.8 M (+0.03 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.17 | 4,957 | 40,495 | 22,860,013 | 22.9 M to 22.9 M (+0.02 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.21 | 6,706 | 55,061 | 22,855,056 | 22.8 M to 22.9 M (+0.03 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.53 | 6,541 | 55,825 | 22,848,350 | 22.8 M to 22.8 M (+0.03 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.17 | 4,957 | 40,495 | 22,860,013 | 22.9 M to 22.9 M (+0.02 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.21 | 6,706 | 55,061 | 22,855,056 | 22.8 M to 22.9 M (+0.03 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.53 | 6,541 | 55,825 | 22,848,350 | 22.8 M to 22.8 M (+0.03 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 8.17 | 4,957 | 40,495 | 22,860,013 | 22.9 M to 22.9 M (+0.02 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 8.21 | 6,706 | 55,061 | 22,855,056 | 22.8 M to 22.9 M (+0.03 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 8.53 | 6,541 | 55,825 | 22,848,350 | 22.8 M to 22.8 M (+0.03 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 8.17 | 4,957 | 40,495 | 22,860,013 | 22.9 M to 22.9 M (+0.02 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 8.21 | 6,706 | 55,061 | 22,855,056 | 22.8 M to 22.9 M (+0.03 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 8.53 | 6,541 | 55,825 | 22,848,350 | 22.8 M to 22.8 M (+0.03 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 8.17 | 4,957 | 40,495 | 22,860,013 | 22.9 M to 22.9 M (+0.02 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 8.21 | 6,706 | 55,061 | 22,855,056 | 22.8 M to 22.9 M (+0.03 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 8.53 | 6,541 | 55,825 | 22,848,350 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.91 | 7,144 | 56,514 | 22,841,809 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.95 | 7,367 | 58,543 | 22,834,665 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 8.30 | 7,500 | 62,244 | 22,827,298 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.91 | 7,144 | 56,514 | 22,841,809 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.95 | 7,367 | 58,543 | 22,834,665 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 8.30 | 7,500 | 62,244 | 22,827,298 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.91 | 7,144 | 56,514 | 22,841,809 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.95 | 7,367 | 58,543 | 22,834,665 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.30 | 7,500 | 62,244 | 22,827,298 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.91 | 7,144 | 56,514 | 22,841,809 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.95 | 7,367 | 58,543 | 22,834,665 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.30 | 7,500 | 62,244 | 22,827,298 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.91 | 7,144 | 56,514 | 22,841,809 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.95 | 7,367 | 58,543 | 22,834,665 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.30 | 7,500 | 62,244 | 22,827,298 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.91 | 7,144 | 56,514 | 22,841,809 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.95 | 7,367 | 58,543 | 22,834,665 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.30 | 7,500 | 62,244 | 22,827,298 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.91 | 7,144 | 56,514 | 22,841,809 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.95 | 7,367 | 58,543 | 22,834,665 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 8.30 | 7,500 | 62,244 | 22,827,298 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.91 | 7,144 | 56,514 | 22,841,809 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.95 | 7,367 | 58,543 | 22,834,665 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 8.30 | 7,500 | 62,244 | 22,827,298 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.58 | 7,189 | 61,694 | 22,819,798 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.35 | 7,500 | 62,594 | 22,812,609 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.97 | 6,649 | 52,959 | 22,805,109 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 8.58 | 7,189 | 61,694 | 22,819,798 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 8.35 | 7,500 | 62,594 | 22,812,609 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.97 | 6,649 | 52,959 | 22,805,109 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.58 | 7,189 | 61,694 | 22,819,798 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.35 | 7,500 | 62,594 | 22,812,609 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.97 | 6,649 | 52,959 | 22,805,109 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 8.58 | 7,189 | 61,694 | 22,819,798 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 8.35 | 7,500 | 62,594 | 22,812,609 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.97 | 6,649 | 52,959 | 22,805,109 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.58 | 7,189 | 61,694 | 22,819,798 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.35 | 7,500 | 62,594 | 22,812,609 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.97 | 6,649 | 52,959 | 22,805,109 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.58 | 7,189 | 61,694 | 22,819,798 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.35 | 7,500 | 62,594 | 22,812,609 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.97 | 6,649 | 52,959 | 22,805,109 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 8.58 | 7,189 | 61,694 | 22,819,798 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 8.35 | 7,500 | 62,594 | 22,812,609 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.97 | 6,649 | 52,959 | 22,805,109 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 8.58 | 7,189 | 61,694 | 22,819,798 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 8.35 | 7,500 | 62,594 | 22,812,609 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.97 | 6,649 | 52,959 | 22,805,109 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 8.00 | 7,082 | 56,621 | 22,798,460 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 8.02 | 6,540 | 52,418 | 22,791,378 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.59 | 7,500 | 56,911 | 22,784,838 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 8.00 | 7,082 | 56,621 | 22,798,460 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 8.02 | 6,540 | 52,418 | 22,791,378 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | Dexxon Holdings Ltd. | 10% Owner | Buy | P | 7.59 | 7,500 | 56,911 | 22,784,838 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.00 | 7,082 | 56,621 | 22,798,460 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 8.02 | 6,540 | 52,418 | 22,791,378 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Buy | P | 7.59 | 7,500 | 56,911 | 22,784,838 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.00 | 7,082 | 56,621 | 22,798,460 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.02 | 6,540 | 52,418 | 22,791,378 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.59 | 7,500 | 56,911 | 22,784,838 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 8.00 | 7,082 | 56,621 | 22,798,460 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 8.02 | 6,540 | 52,418 | 22,791,378 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | Lo Andrew | 10% Owner | Buy | P | 7.59 | 7,500 | 56,911 | 22,784,838 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 8.00 | 7,082 | 56,621 | 22,798,460 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 8.02 | 6,540 | 52,418 | 22,791,378 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | Roivant Sciences Ltd. | 10% Owner | Buy | P | 7.59 | 7,500 | 56,911 | 22,784,838 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.00 | 7,082 | 56,621 | 22,798,460 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 8.02 | 6,540 | 52,418 | 22,791,378 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | Machado Patrick | 10% Owner | Buy | P | 7.59 | 7,500 | 56,911 | 22,784,838 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.00 | 7,082 | 56,621 | 22,798,460 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.02 | 6,540 | 52,418 | 22,791,378 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.59 | 7,500 | 56,911 | 22,784,838 | 22.8 M to 22.8 M (+0.03 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.71 | 5,424 | 41,815 | 22,777,338 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.70 | 5,071 | 39,042 | 22,771,914 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 8.91 | 300 | 2,672 | 22,766,843 | 22.8 M to 22.8 M (0.00 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | SVF Investments (UK) Ltd | 10% Owner | Buy | P | 7.97 | 6,951 | 55,418 | 22,766,543 | 22.8 M to 22.8 M (+0.03 %) |